IL10 and cancer: Since it is known that M2‐like macrophages support cancer cell migration (Joyce & Pollard, 2009), we evaluated the extent of cancer motility trough 8 μm‐pores in presence of macrophages treated for 24 h with IL10 versus glufosinate/or MSO/IL10 and then washed out.